1 Compelling Reason to Buy and Hold TransMedics Group Stock Forever
Donor organs make the difference between life and death for thousands of people every year. But there are two big problems. First, far too few donor organs make it to the intended recipients in shape to be used. Second, too many medical issues occur after organ transplants.Enter TransMedics Group (NASDAQ: TMDX). The company's Organ Care System (OCS) is transforming organ transplantation involving lungs, hearts, and livers by increasing the utilization of donor organs and improving post-transplant clinical outcomes.Cold storage was the standard of care for decades in transplanting donor organs. OCS dramatically improves the utilization of donor organs compared to cold storage using a technology called warm perfusion, which keeps organs alive during transport. It also significantly reduces severe post-transplant complications. And it's the only warm perfusion platform for multiple organs approved by the U.S. Food and Drug Administration (FDA). Continue reading
Donor organs make the difference between life and death for thousands of people every year. But there are two big problems. First, far too few donor organs make it to the intended recipients in shape to be used. Second, too many medical issues occur after organ transplants.
Enter TransMedics Group (NASDAQ: TMDX). The company's Organ Care System (OCS) is transforming organ transplantation involving lungs, hearts, and livers by increasing the utilization of donor organs and improving post-transplant clinical outcomes.
Cold storage was the standard of care for decades in transplanting donor organs. OCS dramatically improves the utilization of donor organs compared to cold storage using a technology called warm perfusion, which keeps organs alive during transport. It also significantly reduces severe post-transplant complications. And it's the only warm perfusion platform for multiple organs approved by the U.S. Food and Drug Administration (FDA).
